GlaxoSmithKline News and Research

RSS

Vaccine shortage complicates efforts to quell hepatitis A outbreaks

San Diego County, battling a deadly outbreak of hepatitis A, is postponing an outreach campaign to provide the second of two inoculations against the contagious liver disease until a national shortage of the vaccine is resolved, the county's chief public health officer said.

14 Nov 2017

CDC recommends new vaccine for shingles

Last month a U.S. Food and Drug Administration (FDA) advisory panel had voted 11 to 0 approving a shingles vaccine for its use in adults aged 50 and over. The panel unanimously accepted the safety and efficacy of the vaccine and thus GlaxoSmithKline’s Shingrix.

25 Oct 2017

Ebola vaccine that provides a year’s worth of protection developed

Liberia’s Ebola outbreak has yielded a successful trial of two vaccines against the deadly infection that could provide protection for up to a year and is also deemed to be safe.

12 Oct 2017

New shingles vaccine gets FDA panel votes

On the 13th of September 2017, a U.S. Food and Drug Administration (FDA) advisory panel has voted 11 to 0 approving a shingles vaccine for its use in adults aged 50 and over. The panel unanimously accepted the safety and efficacy of the vaccine and thus GlaxoSmithKline’s Shingrix is on its way to FDA approval.

14 Sep 2017

Meningitis B vaccine’s high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

8 Sep 2017

Mettler Toledo announce online seminar on continuous flow chemistry

METTLER TOLEDO has announced a new online seminar, titled Flow Chemistry Development and Scale-up. Each presentation includes examples of how simple PAT tools have become integrated into continuous flow chemistry to expedite process development. Each presenter will share a series of technical case studies.

From Mettler-Toledo International Inc. 31 Jul 2017

Developing software for cell and gene therapy supply chain tracking

The first thing is, to always remember that we're dealing with a living drug, cells, which are very sensitive to environmental conditions, such as temperature and humidity etc. All of those things can impact on the viability of the drug and its effectiveness.

18 Jul 2017

Defining patient centricity

"Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best experience and outcome for that person and their family.”

20 Jun 2017

Without Measurement, There is No Control of Aseptic Processes

An interview with Gilberto Dalmaso, discussing the different grades of pharmaceutical cleanrooms and the production of high level compounds under aseptic conditions.

From Particle Measuring Systems 9 Jun 2017

Many COPD patients struggle to pay for each medicinal breath

After a lifetime of smoking, Juanita Milton needs help breathing. She's tethered to an oxygen tank 24/7 and uses two drug inhalers a day, including Spiriva, which she called "the really expensive one."

5 Jun 2017

Lung experts develop new smartphone app for self-management of asthma

A new and unique smartphone app to help people with asthma manage their condition has been developed by lung experts at the Nottingham Respiratory Research Unit and the pharmaceutical company GlaxoSmithKline.

12 Apr 2017

First-in-human study shows positive results for new medicine that could reduce maternal deaths

The Monash University Institute of Pharmaceutical Sciences today announced positive results from a first-in-human study of a new, inhaled form of a medicine that could significantly reduce maternal deaths around the world.

21 Mar 2017

Research findings show effective way to harness anti-tumor potential of macrophages in cancer therapy

For all the success of a new generation of immunotherapies for cancer, they often leave an entire branch of the immune system's disease-fighting forces untapped.

9 Mar 2017

Promising new drug may offer effective treatment for heart failure patients

Heart failure patients who are getting by on existing drug therapies can look forward to a far more effective medicine in the next five years or so, thanks to University of Alberta researchers.

8 Mar 2017

METTLER TOLEDO announces online seminar focusing on crystallization scale-up

METTLER TOLEDO has announced an online seminar focusing on an industrial perspective of successful techniques to develop a scalable crystallization process – Crystallization Scale-up: An Industry Perspective.

From Mettler-Toledo International Inc. 1 Mar 2017

Korn Ferry's Futurestep division partners with GSK to provide recruitment services in Life Sciences sector

Futurestep division of Korn Ferry, the preeminent global people and organisational advisory firm, has been appointed by GlaxoSmithKline, one of the world's largest science-led global healthcare companies, to provide a Flexible Delivery Solution for recruitment support across the United Kingdom, United States and Latin America.

22 Feb 2017

Rapid patient recruitment and reduced trial costs: is LDS the answer?

LDS stands for Linked Database System, which essentially describes what it does. Our LDS technology uses multiple sources of information from hospitals, GPs and pharmacies. However in the future this information could also come from other health data sources e.g. your smartphone, Fitbit etc.

21 Feb 2017

Researchers identify molecular signatures to predict efficacy of malaria vaccines

The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, or biomarkers, in the blood of vaccinated subjects which predict the likelihood of success from vaccination.

13 Feb 2017

WHO confirms pilot deployment of first-generation malaria vaccine in sub-Saharan Africa

The world’s first malaria vaccine will be rolled out in pilot projects in sub-Saharan Africa, WHO confirmed today. Funding is now secured for the initial phase of the programme and vaccinations are due to begin in 2018.

21 Nov 2016

Open-source research mechanism could lead to discovery of new, cheap medicines for malaria

Malaria is one of the leading causes of mortality in developing countries – last year killing more than 400,000 people. Researchers worldwide have found the solution for drug discovery could lie in open, “crowd-sourced” science.

16 Sep 2016